跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TUKYSA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TUKYSA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
TUKYSA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Pfizer Europe Ma Eeig
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 4, 2021
Approval ID
ced5276f603a2a52
Company
Pfizer Europe Ma Eeig
Type
Standard
Approval Details
Approval Id
ced5276f603a2a52
Drug Cima Aemps Name
TUKYSA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1201526002
Holder Company Name
Pfizer Europe Ma Eeig
Marketing Company Name
Pfizer S.L.
Holder Company Detail Path
/organization/pfizer-europe-ma-eeig
Authorization Date
2021-03-04
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Pfizer Europe Ma Eeig
Company Detail Path
/organization/pfizer-europe-ma-eeig
Company Information
Pharmaceutical Company Name
Pfizer Europe MA EEIG
Country Name
United Kingdom
Active Ingredients
TUCATINIB HEMI-ETANOLATO
157,2 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 4, 2021
Approval ID
ced5276f603a2a52
Type
Standard
Back to CIMA-AEMPS Approvals
